Remove Controlled Substances Remove Information Remove Labelling
article thumbnail

Building Intelligent Pharma Supply Chain Management with Real-World Data

Pharmaceutical Commerce

Drug tracking data, purchasing information, and usage trends can all be meaningfully applied to build models that generate actionable insights that enhance efficiency, ensure that therapies are available when and where they are needed, enable smarter inventory control, and improve predictive analytics.

article thumbnail

To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential

Pharmacy Times

Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. 1-3 Detect-A-Dose Lid Label Covers. 4 Detect-A-Dose features a contrasting black and white pattern on the underside of its label to make missing doses for patients apparent to pharmacists.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Changes Opioid Pain Medication Labeling Requirements

PharmaTech

Required labeling updates include clearer risk information, stronger warnings, and guidance on opioid use, with a 30-day submission deadline for manufacturers. Required labeling updates include clearer risk information, stronger warnings, and guidance on opioid use, with a 30-day submission deadline for manufacturers.

article thumbnail

FDA Seeks $7.2 Billion to Protect and Advance Public Health

LifeProNow

million in investments in food safety and nutrition modernization, including food labeling and animal food safety oversight. Funding will support broader development of opioid overdose reversal treatments and treatments for substance use disorders and enhance regulatory oversight, expand compliance, enforcement and laboratory support.

article thumbnail

Florida approved to import Canadian prescription drugs

Pharma in Brief

Eligible drugs must: (i) be approved by Health Canada; and (ii) meet FDA-approval conditions for a drug currently marketed in the US (aside from US labeling). Biologics, controlled substances, and certain other drugs are not eligible for importation. 01.014.13). 01.014.13).

article thumbnail

OPDP Comes out Swinging With A Warning Letter on Unsubstantiated Efficacy

FDA Law Blog: Biosimilars

By Dara Katcher Levy — Well, if you, like many within industry, felt emboldened to disseminate promotional materials that may push the envelope on efficacy (so long as your risk information was tight) think again! Let’s go over some background information relating to Breztri and the OPDP Warning Letter. Pretty egregious stuff, right?

article thumbnail

Health Canada issues new Interim Order to prevent bulk exportation of prescription drugs from Canada

Pharma in Brief

of the US Importation Rule, drugs eligible for importation must have received an NOC and DIN in Canada and meet FDA approval conditions, aside from US labeling. Controlled substances, biologics, and certain injectable drugs are not eligible for importation. Interim Order Context. Interim Order: Safeguarding the Drug Supply.